944389-99-5Relevant academic research and scientific papers
Oxotetrahydrothiophenes
-
, (2008/06/13)
Biological activity is retained while reducing toxicity to animals, particularly mammals, e.g. humans, when a physiologically-active and pharmacologically-acceptable compound (having or structurally modified to have an aldehyde function) is condensed with any of the six (mono)amino(mono)oxotetrahydrothiophenes, e.g. homocysteine thiolactone, to form a Schiff Base (a 4-butyrothiolactone-2-imine or γ-thiobutyrolactone-α-imine). The invention is directed to every Schiff Base which is a condensate of a physiologically-active and pharmacologically-acceptable compound with a (mono)amino(mono)oxotetrahydrothiophene. These Schiff Bases have a unifying common property in reduced toxicity, while maintaining the biological properties "carried" by the imine substituents. They concurrently have at most an insignificant adverse affect on pharmacological activity.
